VBI Vaccines lands $50m debt financing

K2 HealthVentures has agreed to provide $50 million in debt financing to Cambridge, Massachusetts-based VBI Vaccines Inc, a developer of next-generation infectious disease and immuno-oncology vaccines.

Share this